This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest

COVID-19 intensifies need for and uptake of digital healthcare
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions

Exploring the role of EI in partnerships for OINDP development
Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Sustainability, Innovation & Insights, Drug Delivery Innovations

The Need to Scale Up Digital Health in the Post-Covid World
Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions

Using Bioequivalence and Particle Size Distribution to Develop OINDPs
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions